M. Jain | Turku Hypertension Center

Latest

Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting
Phylogeny-Aware Analysis of Metagenome Community Ecology Based on Matched Reference Genomes while Bypassing Taxonomy
A plasma metabolite score of three eicosanoids predicts incident type 2 diabetes: a prospective study in three independent cohorts
Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort
Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults
Efficient computation of Faith's phylogenetic diversity with applications in characterizing microbiomes
Associations of healthy food choices with gut microbiota profiles
Taxonomic signatures of cause-specific mortality risk in human gut microbiome
Links between gut microbiome composition and fatty liver disease in a large population sample
An Early-Onset Subgroup of Type 2 Diabetes: A Multigenerational, Prospective Analysis in the Framingham Heart Study
Eicosanoid Inflammatory Mediators Are Robustly Associated With Blood Pressure in the General Population
Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals
Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity
A Single Visualization Technique for Displaying Multiple Metabolite-Phenotype Associations
Statistical Workflow for Feature Selection in Human Metabolomics Data
Directed Non-targeted Mass Spectrometry and Chemical Networking for Discovery of Eicosanoids and Related Oxylipins
Trajectories of Blood Pressure Elevation Preceding Hypertension Onset: An Analysis of the Framingham Heart Study Original Cohort